PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles

Cancer Cell - United States
doi 10.1016/j.ccr.2011.01.047
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

PARP Inhibitors in Cancer Therapy: Magic Bullets but Moving Targets

Frontiers in Oncology
Cancer ResearchOncology
2013English

PARP Inhibitors in Ovarian Cancer

2013English

Breast Cancer: Progress and Promise

Oncologist
Cancer ResearchMedicineOncology
2011English

Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy

Frontiers in Pharmacology
Pharmacology
2020English

PARP Inhibitors and Stratified Treatment of Prostate Cancer

Expert Review of Anticancer Therapy
OncologyPharmacology
2016English

Breast Cancer: Progress and Promise—Part 1

Oncologist
Cancer ResearchMedicineOncology
2010English

PARP Inhibitors in Ovarian Cancer: Sensitivity Prediction and Resistance Mechanisms

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Extending the Scope of PARP Inhibitors in Ovarian Cancer

The Lancet Oncology
Oncology
2019English

Personalized Cancer Medicine: Era of Promise and Progress

Nature Reviews Clinical Oncology
Oncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy